MedPath

Investigating the Impact of AI on Shared Decision Making in Post-kidney Transplant Care

Not Applicable
Active, not recruiting
Conditions
Kidney Transplant Failure
Interventions
Other: AI-based risk prediction for kidney graft loss
Registration Number
NCT06056518
Lead Sponsor
Charite University, Berlin, Germany
Brief Summary

This study aims to analyze the effects of AI-based risk prediction for graft loss on the frequency of conversations about the treatment after graft loss, as well as the associated shared decision making process in post-kidney transplant care in a German kidney transplant center (KTC), as perceived by the patient, their support person and the clinician/physician. Second, it aims to explore changes in patient and support person recall at 12 and 24 months follow-up. Implementation barriers and enablers will also be assessed.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
76
Inclusion Criteria
  • written informed consent
  • patients with functioning kidney allograft
  • > 12 months after transplantation
  • eGFR < 30 ml/min/1.73m2 according to CKD-EPI 2021 formula
  • at least 18 years of age
  • ability to communicate in German
  • regular follow-up at kidney transplant center
Exclusion Criteria
  • multi-organ transplantation
  • eGFR > 30 ml/min/1.73m2 according to CKD-EPI 2021 formula
  • <= 12 months after transplantation
  • less than 18 years of age
  • not able to communicate in German
  • no regular follow-up at kidney transplant center
  • enrollment in another interventional study less than 1 month before participation in this study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AI-supported CareAI-based risk prediction for kidney graft lossPatients in the "AI-supported Care" arm will undergo regular follow-up at the kidney transplant center. Treating physicians will be provided an AI-based risk prediction tool that predict 1-year risk of graft loss for patients in this group based on routine parameters.
Primary Outcome Measures
NameTimeMethod
Conversation about kidney replacement therapy after graft loss12 months

Proportion of patients, with whom the necessity of kidney replacement therapy after kidney allograft loss is discussed

Secondary Outcome Measures
NameTimeMethod
CollaboRATE mean score after 24 months24 months

CollaboRATE mean score of all study visits from study inclusion until month 24 (values 0 - 9, higher values indicating better outcome)

Control Preferences Scale mean after 24 months24 months

Mean Control Preferences Scale of all study visits from study inclusion until month 24 (values 1 - 5, higher values indicating better outcome)

Kidney replacement therapy 12 months12 months

Frequency of kidney replacement therapy after graft loss 12 months

Dialysis initiation via AV-shunt 12 months12 months

Frequency of dialysis initiation via AV-shunt after graft loss 12 months

Conversation about kidney replacement therapy after graft loss24 months

Proportion of patients, with whom the necessity of kidney replacement therapy after kidney allograft loss is discussed

Kidney replacement therapy 24 months24 months

Frequency of kidney replacement therapy after graft loss 24 months

Dialysis initiation via AV-shunt 24 months24 months

Frequency of dialysis initiation via AV-shunt after graft loss 24 months

Emergency dialysis 24 months24 months

Frequency of emergency dialysis after graft loss 24 months

Retransplantation 12 months12 months

Frequency of retransplantation after graft loss 12 months

Dialysis initiation via permanent catheter 24 months24 months

Frequency of dialysis initiation via permanent catheter after graft loss 24 months

CollaboRATE mean score after 12 months12 months

CollaboRATE mean score of all study visits from study inclusion until month 12 (values 0 - 9, higher values indicating better outcome)

Control Preferences Scale mean after 12 months12 months

Mean Control Preferences Scale of all study visits from study inclusion until month 12 (values 1 - 5, higher values indicating better outcome)

Emergency dialysis 12 months12 months

Frequency of emergency dialysis after graft loss 12 months

Dialysis initiation via permanent catheter 12 months12 months

Frequency of dialysis initiation via permanent catheter after graft loss 12 months

Retransplantation 24 months24 months

Frequency of retransplantation after graft loss 24 months

Trial Locations

Locations (1)

Charité - Universitätsmedizin Berlin

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath